Different groups are consuming COVID-19 information in distinct ways. Public health messaging must recognize this and adjust content and dissemination strategies to meet users where they are.
Read more
Authors of a new article in JPHMP share findings from surveying people experiencing predominantly unsheltered homelessness in Las Vegas, NV, and Orlando, FL about motivators, barriers, and receipt of COVID-19 vaccination during 2021.
Read more
Maya Scherer and Alexandra Kamler describe the value of using public deliberation to set priorities for COVID-19 vaccine distribution for essential workers in New York City. During 2020, in anticipation of a limited supply of vaccine in New York City (NYC), the NYC Department of Health and Mental Hygiene sought guidance from members of the public about the fairest approach
Read more
Authors of “The Yellow Fever Vaccine Misadventure of 1942” respond to a tweet by Candace Owens. Exactly 80 years ago today, war with Japan was imminent. The US Naval fleet at Pearl Harbor had been attacked; the Japanese surrounded Shanghai, and the Germans already had a foothold in Africa. The yellow fever vaccination campaign, initiated in 1941, was expedited after
Read more
What the conversation about COVID-19 vaccines can teach us about how to navigate the social compact between voices of authority and the populations they serve. This post originally appeared on The Healthiest Goldfish with Sandro Galea and is republished here with permission from the author. Learn more at SandroGalea.org. Over the last year or so there has been much criticism of leadership in
Read more
by Lloyd F. Novick, MD, MPH The Editor’s Podcast appears with each new issue of the Journal of Public Health Management and Practice and offers a closer look at the articles published in the latest issues with guest appearances by authors, guest editors, and others. On March 11, 2021, President Biden signed a $1.9 trillion COVID relief package into law
Read more
by Lloyd F. Novick, MD, MPH The Editor’s Podcast with Dr. Lloyd F. Novick offers a closer look at the latest articles published in the Journal of Public Health Management and Practice, as well as discussions with public health leaders on related topics. In this episode of the Editor’s Podcast, I speak with a JPHMP editorial board member who is
Read more
The race to find a cure for SARS-CoV-2, the virus that causes COVID-19, is heating up around the world as countries battle to see which one can produce a winner first. While Russia announced it has a vaccine that it expects to be approved this month that it plans to administer in a mass vaccination campaign in October, the Chinese
Read more
by Toby D. Terwilliger, MD As several promising SARS-CoV-2 vaccines enter into Phase II and III clinical trials, it is incumbent on physicians and public health officials to keep the public informed regarding the requisite process of vaccine development. It is eminently imaginable that we may find ourselves in a situation where certain politicians pressure the FDA, pharmaceutical companies, and
Read more
by Stephen Berger, MD As of April 10, 2020, thirty-one individual drugs had been suggested for the treatment of COVID-19. And as of that date, none was proven to be effective. The most contentious issue in all of this is the word “proven.” Over 330 agents are used in the field of Infectious Disease, sold under more than 29,300
Read more
You must be logged in to post a comment.